Biodesix Inc (NASDAQ:BDSX) has a beta value of 1.05 and has seen 0.2 million shares traded in the last trading session. The company, currently valued at $143.29M, closed the last trade at $0.99 per share which meant it gained $0.03 on the day or 2.28% during that session. The BDSX stock price is -106.06% off its 52-week high price of $2.04 and 13.13% above the 52-week low of $0.86. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.35 million shares traded. The 3-month trading volume is 494.02K shares.
The consensus among analysts is that Biodesix Inc (BDSX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Biodesix Inc (NASDAQ:BDSX) trade information
Sporting 2.28% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the BDSX stock price touched $0.99 or saw a rise of 2.24%. Year-to-date, Biodesix Inc shares have moved -35.62%, while the 5-day performance has seen it change -1.50%. Over the past 30 days, the shares of Biodesix Inc (NASDAQ:BDSX) have changed -11.26%. Short interest in the company has seen 0.75 million shares shorted with days to cover at 1.56.
Wall Street analysts have a consensus price target for the stock at $3, which means that the shares’ value could jump 67.0% from current levels. The projected low price target is $3.0 while the price target rests at a high of $3.0. In that case, then, we find that the current price level is -203.03% off the targeted high while a plunge would see the stock gain -203.03% from current levels.
Biodesix Inc (BDSX) estimates and forecasts
The company’s shares have lost -42.73% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 8.42% over the past 5 years. Earnings growth for 2025 is a modest 45.59% while over the next 5 years, the company’s earnings are expected to increase by 37.89%.
BDSX Dividends
Biodesix Inc is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Biodesix Inc (NASDAQ:BDSX)’s Major holders
Insiders own 48.62% of the company shares, while shares held by institutions stand at 40.46% with a share float percentage of 78.75%. Investors are also buoyed by the number of investors in a company, with Biodesix Inc having a total of 69.0 institutions that hold shares in the company. The top two institutional holders are TELEMARK ASSET MANAGEMENT, LLC with over 8.28 million shares worth more than $12.67 million. As of 2024-06-30, TELEMARK ASSET MANAGEMENT, LLC held 6.513% of shares outstanding.
The other major institutional holder is SOLEUS CAPITAL MANAGEMENT, L.P., with the holding of over 6.11 million shares as of 2024-06-30. The firm’s total holdings are worth over $9.35 million and represent 4.8062% of shares outstanding.
